CTRI/2019/09/021265Completed未知
Prefrontal Cortex Gyrification, Cortical thickness,Grey Matter volume and executive functions in Patients with Schizophrenia- A comparative study
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 45
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1. First episode schizophrenia duration of illness 6 month or less.
- •2.Chronic Schizophrenia illness more than 2 year.
- •3.No comorbid psychiatric illness or substance dependence
- •4. Educated upto 8 class
- •5.Giving written consent
Exclusion Criteria
- •1.Current neurological or comorbid psychiatric disorder
- •2. History of substantial brain damage or any neurological procedures.
- •3. Metallic implants.
- •4.Score of more than 3 on general health questionnaire-12
- •5. Not giving written informed consent.
Investigators
Similar Trials
Recruiting
Not Applicable
The relationship between prefrontal cortex activation and motor function during a dual task walkingHealthy peopleJPRN-UMIN000038844Tohoku University Graduate School of Biomedical Engineering36
Recruiting
Not Applicable
Plasticity in prefrontal cortical regions in humans: genetic variation, cellular mechanisms and modulation by means of neurofeedbackhaelthy subjectsDRKS00004252Zentralinstitut für Seelische Gesundheit100
Active, not recruiting
Not Applicable
Examining non-invasive brain stimulation for the treatment of depressioISRCTN26184028Czech Health Research Agency60
Recruiting
Not Applicable
Frontal brain Transcranial Magnetic Stimulation for Craving reduction in SmokersCigarette smokingMental and behavioural disorders due to use of tobacco - dependence syndrome.C25.775.912F17.2RBR-6bqp2pSingular Psiquiatria e Neuromodulação
Active, not recruiting
Phase 1
Corticodependent or corticoresistant brain radionecrosis after radiotherapy for brain metastases: a multicentre randomized, controlled double-blind phase III study, comparing bevacizumab versus placebo (BRADI)Brain metastases of cancer > brain radionecrosisCTIS2024-510893-25-00Institut De Cancerologie De L Ouest84